PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Dermatology Department, Centro Universitário Saúde ABC, Santo André, Brazil.\', \'Dermatology Department, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.\', \'Pathology Department, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1111/dth.14068
?:hasPublicationType
?:journal
  • Dermatologic therapy
is ?:pmid of
?:pmid
?:pmid
  • 32713127
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.625
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all